Could a probiotic help kids with type 1 diabetes? new study explores
NCT ID NCT03961854
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a probiotic called Lactobacillus johnsonii N6.2 is safe and affects the immune system in 30 children and teens with type 1 diabetes. The goal was to see if the probiotic could help preserve the body's ability to produce insulin by improving gut health. Participants took the probiotic for 24 weeks and were monitored for side effects and changes in blood and stool samples.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UF Clinical Research Center
Gainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Open-Source insulin systems match commercial ones without meal announcements?
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Immune cell study may unlock kidney protection in type 1 diabetes
- Could an arthritis drug stop type 1 diabetes before it starts?